<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04120870</url>
  </required_header>
  <id_info>
    <org_study_id>MED-OBS-19-294</org_study_id>
    <nct_id>NCT04120870</nct_id>
  </id_info>
  <brief_title>Comparison of Ketamine and Etomidate During Rapid Sequence Intubation in Trauma Patients</brief_title>
  <official_title>Comparison of Effects on Hemodynamics Between Ketamine and Etomidate During Rapid Sequence Intubation in Trauma Patients With High Shock Index</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ajou University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Unimedics (http://unimedics.co.kr)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ajou University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In trauma patients with high shock index, the investigators compare the effects on&#xD;
      hemodynamics between ketamine and etomidate.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In trauma patients, rapid sequence intubation is recommended. The drug of choice, however,&#xD;
      has been debated. One cohort comparative study showed ketamine had benefit in hemodynamics&#xD;
      compared to etomidate in trauma patients. One observational study showed in high shock index&#xD;
      patients, ketamine showed maintain systolic blood pressure. And other retrospective showed&#xD;
      less clinical hypotension was less in ketamine. However there is no randomized controlled&#xD;
      study comparing ketamine and etomidate in trauma patients. The purpose of this study is&#xD;
      comparing the effects of hemodynamics between ketamine and etomidate in high shock index&#xD;
      trauma patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2019</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>ketamine group: ketamine 2 mg/kg iv as induction agent etomidate group: etomidate 0.2 mg/kg iv as induction agent</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>open label</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Systolic blood pressure difference compared with baseline after 10 minutes</measure>
    <time_frame>13 minutes</time_frame>
    <description>Systolic blood pressure 10 minutes after induction agent injection - baseline systolic blood pressure mmHg Positive or zero value means good result. Negative value means poor result.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intubating condition</measure>
    <time_frame>5 minutes</time_frame>
    <description>Intubator judge intubating condition Laryngoscopy: easy / fair / difficult (difficult is the worst result) Vocal cords position: abducted / moving / closed (closed is the worst result) Reaction to insertion of the tracheal tube and cuff inflation : none / slight / vigorous (none is the worst result)&#xD;
If one of category checked the worst score, it considered :clinically unacceptable&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of hypotension</measure>
    <time_frame>25 minutes</time_frame>
    <description>If any of these are checked, define as hypotension (from injection of induction agent to 20 minutes after)&#xD;
systolic pressure &lt; 90 mmHg&#xD;
systolic pressure decrease &gt; 40% compared to baseline&#xD;
Initiation of vasopressor&#xD;
Vasopressor dose increase &gt; 30% of initial vaopressor dose&#xD;
Fluid or blood loading&#xD;
Patient numbers (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of hypertension</measure>
    <time_frame>25 miinutes</time_frame>
    <description>From injection of induction agent to 20 minutes after, systolic pressure &gt; 160 mmHg defined as hypertension&#xD;
Patients numbers (%)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Trauma</condition>
  <condition>Shock, Traumatic</condition>
  <arm_group>
    <arm_group_label>Etomidate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The induction agent of rapid sequence intubation is etomidate. 0.2 mg/kg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The induction agent of rapid sequence intubation is ketamine. 2 mg/kg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Etomidate Injection 0.2 mg/kg</intervention_name>
    <description>The induction agent of rapid sequence intubation is etomidate. 0.2 mg/kg</description>
    <arm_group_label>Etomidate</arm_group_label>
    <other_name>Etomidate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine injection 2 mg/kg</intervention_name>
    <description>The induction agent of rapid sequence intubation is ketamine. 2 mg/kg</description>
    <arm_group_label>Ketamine</arm_group_label>
    <other_name>Ketamine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age 19~70&#xD;
&#xD;
          -  Shock index â‰¥ 0.9&#xD;
&#xD;
          -  Patients who need intubation regarding to Ajou trauma center protocol&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  during CPR&#xD;
&#xD;
          -  CPR before hospital arrival&#xD;
&#xD;
          -  Severe head trauma&#xD;
&#xD;
          -  Steroid intake history&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>In Kyong Yi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ajou University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>In Kyong Yi, MD</last_name>
    <phone>+82-31-219-7522</phone>
    <email>lyrin01@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yo Heo, MD</last_name>
    <phone>+82-31-219-7492</phone>
    <email>107696@aumc.ac.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ajou university school of medicine</name>
      <address>
        <city>Suwon</city>
        <state>Gyeonggi-do</state>
        <zip>16499</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>In Kyong Yi, MD</last_name>
      <phone>+82-10-3012-6972</phone>
      <email>lyrin01@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Yoon Jung Chae, MD</last_name>
      <phone>+82-31-219-5689</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>September 26, 2019</study_first_submitted>
  <study_first_submitted_qc>October 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2019</study_first_posted>
  <last_update_submitted>January 12, 2021</last_update_submitted>
  <last_update_submitted_qc>January 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ajou University School of Medicine</investigator_affiliation>
    <investigator_full_name>In-kyong Yi</investigator_full_name>
    <investigator_title>Clinical assistant professor</investigator_title>
  </responsible_party>
  <keyword>etomidate</keyword>
  <keyword>ketamine</keyword>
  <keyword>rapid sequence intubation</keyword>
  <keyword>trauma</keyword>
  <keyword>hemodynamics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Traumatic</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Etomidate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>If there is a reasonable request, we can share the data personally.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

